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Abstract Introduction: The primary objectives were to
compare the duration of sickness absence in employees
with high levels of somatic symptom severity (HLSSS)
with employees with lower levels of somatic symptom
severity, and to establish the long-term outcomes con-
cerning return to work (RTW), disability and discharge.
Secondary objective was to evaluate determinants of the
duration of sickness absence in employees with HLSSS.
Methods: 489 sick-listed employees registered with five
Occupational Health Physician (OHP) group practices were
included in this study. We measured their baseline scores
for somatic symptoms severity, depressive disorders, anx-
iety disorders, health anxiety, distress and functional
impairment. The OHPs filled in a questionnaire on their
diagnosis. A prospective 2-year follow-up was carried out
to assess the long-term outcomes concerning sickness
absence, and retrospective information was gathered with
regard to sickness absence during the 12 months before the
employees were sick-listed. Results: The median duration
of sickness absence was 78 days longer for employees with
HLSSS. They more often remained disabled and were
discharged more often, especially due to problems in the
relationship between the employer and the employee.
HLSSS, health anxiety and older age contributed to a
longer duration of sickness absence of employees. Con-
clusion: High levels of somatic symptom severity are a
determinant of prolonged sickness absence, enduring dis-
abilities and health-related job loss. Occupational health
physicians should identify employees who are at risk and
adhere to guidelines for medically unexplained somatic
symptoms.
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Introduction
Kroenke et al. [1] found that patients with high levels of
somatic symptom severity (HLSSS) constituted 10 and 9%
of samples in primary care and medical outpatient popu-
lations. These patients were severely bothered by multiple
common somatic symptoms like fatigue, dizziness, and
non-cardiac chest pain. The prevalence of HLSSS is in the
same range as abridged somatization disorder, which is a
clinical meaningful subthreshold somatoform disorder [2],
whereby for this diagnosis it is needed that medical
explanations are excluded and that the somatic symptoms
resulted in medical help seeking behavior. HLSSS in
patient samples are associated with reduced health-related
functioning [3], disabilities and sickness absence, even
after adjustment for psychiatric and medical co-morbidity
[4, 5]. These associations with reduced functioning are
linear with the level of somatic symptom severity [1].
Patients with long lasting medically unexplained somatic
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symptoms are more often disabled and unemployed [6].
Although single somatic symptoms are often self-limiting,
patients with multiple somatic symptoms have a lower
recovery rate [7]. About 15–30% of the patients with
medically unexplained somatic symptoms or somatization
do not recover or get worse [8].
In the working population the level of somatic symptom
severity is much lower [9] than in the sick-listed population
[10–12], where we found a prevalence of HLSSS of 15%
[12]. There is limited information about the ‘transitions’
from healthy working employees, to employees with
HLSSS and sickness absence, and subsequently to
employees with chronic disability and to unemployment.
Higher levels of somatic symptom severity are in the
working population associated with reduced health-related
functioning [11], frequent sickness absence [13], a longer
duration of sickness absence [11] and higher risk of a
disability pension [10]. An employee’s expectation of a
long sickness absence and an increase in pain predict
barriers for return to work (RTW) [14]. These findings give
rise to our hypothesis that high levels of somatic symptom
severity will result in longer duration of sickness absence
and may result in more lasting disabilities.
With regard to unemployment, Haahr et al. [15] found
that health-related job loss (HRJL) was associated with
body discomfort due to musculoskeletal pain, high pain
levels, health worries and stress-related problems.
Although it was not verified if the musculoskeletal pain
was non-specific, this study gives an indication that HLSSS
may result in more unemployment.
However, there is a lack of longitudinal studies of
employees, measured with validated instruments to deter-
mine the course of medically unexplained somatic symp-
toms and related outcomes. We report here on a 2-year
follow-up of a sample of long-term sick-listed employees
with HLSSS and lower levels of somatic symptom severity,
in order to test our hypothesis that employees with HLSSS
are more at risk for lasting disabilities and discharge.
The research questions we addressed in this study were:
1. What is the duration of sickness absence in sick-listed
employees with HLSSS, compared to sick-listed
employees with lower levels of somatic symptom
severity and what was the duration and frequency of
sickness absence 1 year before the sick-listed period?
2. What are the long-term outcomes in terms of complete
RTW, disability and discharge for sick-listed employ-
ees with HLSSS compared to sick-listed employees
with lower levels of somatic symptom severity?
3. What are the determinants of the duration of sickness
absence in sick-listed employees with HLSSS?
Methods
Introduction
The law in the Netherlands states that employees who
report sick must be seen before the sixth week of sick-leave
(first consultation) by an occupational health physician
(OHP), who will establish the diagnosis, the disabilities,
and the prognosis for RTW. The maximum period of
sickness certification is 2 years, after which an employee
who is still disabled can apply for a state disability pension.
However, an employer can choose to pay the employee for
a longer period of sickness absence with a maximum of
3 years. This happens mainly in local and central govern-
ment. Most of the visits made by the employees to OHPs in
the Netherlands concern consultations for sickness
certification.
Design
We carried out an observational study with a prospective
follow-up of 2 years and a 1-year period of retrospective
data collection.
Patients
Sick-listed employees were included in the study from
April 2006 until December 2007. Their characteristics are
described in Table 1.
OHPs
A total of 43 OHPs from five group practices in two large
occupational health services in the Netherlands participated
in this study. The group practices, located in four different
geographical regions of the Netherlands, provide services
for organisations of different sizes and branches located in
urban and rural areas (Table 2).
Data-Collection
In the inclusion period the employee questionnaires and
the OHP questionnaires were gathered during a period of
6 weeks in each of the five group practices. Follow-up
ended March 2009 with gathering the data for 2 years
follow-up of employees from the first four group practices
and for 1 year follow-up of employees from the fifth
group. Data on sickness absence were gathered from the
information systems of the two occupational health
services.
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Measurements
Patient Questionnaires
The employees were asked to answer questions about
socio-demographic variables and to fill in the following
questionnaires, to measure:
(a) Somatic symptom severity, with the somatization
module of the PHQ, the PHQ-15 [3, 16]. The PHQ-15
assesses how much the patient has been bothered
during the past month (score 0–2; ranging from not
bothered at all to bothered a lot) by 15 common
physical complaints. These complaints are moder-
ately related to a history of medically unexplained
Table 1 Baseline characteristics of the study population
PHQ 15?
N = 74
PHQ 15-
N = 415
P-valuea
Female (%) 73.0 56.6 0.008
Age mean (SD) 42.5 (9.2) 45.0 (10.0) 0.040b
Education high/average/low (%) 20.0/55.7/24.3 35.5/44.8/19.6 0.031c
Autochton (%) 75.3 88.6 0.002
Married/living together/alone (%) 46.6/11.0/42.5 57.7/14.7/27.6 0.038
PHQ-15 mean (SD) 19.2 (2.6) 8.2 (3.9) \0.001d
Duration of sickness absence (days) median (IQR) (N = 409) 340 (158–729) 262 (131–450) 0.039d
Total sickness absence 1 year before inclusion period (days) median (IQR) (N = 409) 9 (0–35) 8 (0–29) 0.730d
Frequency of sickness absence 1 year before inclusion period median (IQR) (N = 409) 1 (0–3) 1 (0–3) 0.849d
Mental diagnosis (%) 62.2 39.8 \0.001
Musculoskeletal diagnosis (%) 10.3 29.6 \0.001
Other diagnosis (%) 27.0 30.6 0.537
SF physical functioning 55.3 (24.0) 71.6 (23.8) \0.001d
SF role functioning physical 12.7 (28.0) 28.4 (37.0) \0.001d
SF bodily pain 36.6 (22.8) 56.3 (27.5) \0.001b
SF general health perceptions 38.2 (15.0) 57.0 (19.7) \0.001b
SF vitality 26.6 (16.8) 47.9 (21.6) \0.001b
SF social functioning 36.8 (25.2) 56.6 (26.0) \0.001b
SF role functioning mental 19.3 (36.3) 58.3 (43.7) \0.001d
SF mental health 41.1 (22.2) 64.2 (21.6) \0.001d
a v2 test; b Independent students’ t test; c v2 trend test; d Mann–Whitney U test
Table 2 OHP characteristics
Group practice 1 2 3 4 5
No. of OHPs 13 7 6 8 9 43
Size of organisations [500 employees [500
employees
\75
employees
\75 and 75–500
employees
[500 employees
Main branches Public services, education
and health service
Government All types All types Public services,
financial services
and local government
Urbanisation Urban Urban Rural Urban Mixed
Age mean (SD) 48.7 (6.5) 45.1 (5.6) 42.2 (9.7) 46.3 (7.4) 47.8 (5.3) 46.5 (6.9)
Female (%) 30.8 71.4 50.0 50.0 87.5 54.8
Work experience (years)
(SD)
13.4 (6.2) 13.4 (2.4) 9.5 (7.7) 11.1 (4.3) 12.3 (3.4) 12.2 (5.1)
Working hours % of
full-time mean (SD)
89.2 (13.2) 76.4 (13.8) 91.7 (16.0) 77.5 (16.7) 81.3 (25.3) 83.7 (17.4)
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symptoms [17] and are associated with significant
impairment in health-related functioning [1]. Cut-off
levels are 0, 5, 10 and 15 for minimal, low, medium
and high levels of somatic symptom severity. The cut-
off point of 15 for high levels of somatic symptoms
severity (PHQ-15 C 15) is comparable with clinically
representative samples of somatoform disorders with
a lower threshold than somatisation disorder [17]. The
internal consistency of the PHQ-15 is good (Cron-
bach’s a = 0.80) [3, 18]. Its sensitivity and specificity
have been established in a primary care population as
78% and 71%, respectively, at a cut-off level of 3
symptoms or more, with a low positive predictive
value and a high negative predictive value [18]. Its
test–retest reliability is moderate with a score of 0.60.
Although limited research has focused on this ques-
tionnaire it seems to be reliable for the identification of
patients who are at risk for somatoform disorders [18].
(b) Depression, with the depression module of the Patient
Health Questionnaire (PHQ-9) [16, 19]. The PHQ-9
rates how much the patient has been bothered during
the past 2 weeks (score 0–3) by 9 symptoms of
depression. Total scores for the 9 symptoms range
from 0 to 27, with a cut-off point of 15 (PHQ-9 C 15)
for severe levels of depression. Two questions (about
feeling tired and sleeping problems), in the PHQ-9 are
also included in the PHQ-15. Although this makes the
PHQ-9 score less independent of the PHQ-15 score, it
has been reported to have high construct validity and
strong associations with clinical variables in the
general population [19]. Algorithms, based on the
Diagnostic and Statistical Manual of Mental Disorders,
Fourth Edition (DSM-IV) criteria, are applied to help
the physician to discern a major depressive disorder
from any depressive disorder (excluding the other
diagnosis).
(c) Anxiety disorders, with the anxiety module of the
Patient Health Questionnaire (PHQ) [16, 20]. This
subscale of the PHQ contains 15 yes/no questions about
anxiety and panic symptoms, and is used with algo-
rithms for panic disorder and other anxiety disorders.
The algorithm for panic disorder is the most valid, with
a sensitivity of 75% and a specificity of 96% [20].
(d) Health anxiety, with the Whitely Index (WI). This 14-
item yes/no self-report questionnaire, which was
designed to assess hypochondriasis [21], can be used
to measure levels of health anxiety. Higher levels of
health anxiety are related to less symptom recovery
after 1 year [22].
(e) Distress, with the distress module of the 4-Dimen-
sional Symptom Questionnaire (4DSQ) [9, 23]. This
Dutch questionnaire is internally consistent, with a
Cronbach’s alpha of 0.90 for distress. Total distress
scores for the sixteen distress items range from 0 to
32, with a cut-off point of 20 for severe distress.
(f) Functional impairment, with a Dutch translation of the
Short Form Health Survey (SF-36) [24]. The SF-36 is
well validated [25] and measures eight aspects of
health-related quality of life.
OHP Questionnaire—Employee and Consultation
Characteristics
This OHP questionnaire contained questions about the
presence of physical symptoms, the causes to which the
employees attributed their physical complaints (physi-
cal, mental or physiologic), and the diagnosis made by the
OHP (categorized as musculoskeletal, mental and other
disorders).
Information About Sickness Absence
Information about duration and frequency of sickness
absence was gathered from the registration systems of the
occupational health services. The following data were
retrieved:
– Duration in days of sickness absence during the period
in which the employee was included, this will be
further referred to as ‘baseline sickness absence’, with
retrospective gathering of the starting date on this
sickness-absence period and a maximum follow-up
period of 2 years after inclusion. Partial RTW was not
measured, only duration until complete RTW (as
duration of sickness absence).
– Sickness absence periods (duration in days and number
of periods) in the 12 months prior to the baseline
sickness absence.
The long-term outcome of the sickness absence from
inclusion was retrieved from the registration systems of the
occupational health services and classified as:
1. Ending sickness absence due to:
– complete return to own work (RTW) and no new
period of sickness absence within 4 weeks after
complete RTW;
– complete RTW to different work (although no
continued disability and with the same salary);
– pregnancy leave;
– discharge.
2. Continued disability:
– disabled for own work, doing no work at all, doing
partially own work, doing partially or completely
different work due to the disability, no disability
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pension but less salary, applying for disability
pension, or receiving a disability pension;
– disabled and discharge due to total and permanent
occupational disability;
– disabled and discharge due to problems in the
employer–employee relationship.
3. Unknown:
– employer changed to another occupational health
service;
– outcome not registered.
The information about the employees included by one of
the occupational health services was retrieved by the main
author from the central information system. The informa-
tion about the employees included by the other occupa-
tional health service was provided by the participating
OHPs, because they had no central registration system.
Data-Analysis
A missing value analysis was performed for baseline data
on age, gender, level of education, ethnicity, and missing
PHQ score at follow-up.
In the analysis on duration of sickness absence,
employees were dichotomized into employees with
HLSSS, categorised as the PHQ C 15 group (the PHQ 15?
group), and the employees with moderate, mild or minimal
somatic symptom severity, categorised as the PHQ \ 15
group (the PHQ 15- group). Independent Student t-tests
were performed for continuous variables, and Mann–
Whitney U tests were performed for non-parametric dis-
tributions. Chi-square tests were performed for categorical
variables. Chi-square trend tests were performed to inves-
tigate trends for ordinal variables.
We censored all data on the duration of sickness absence
to 2 years, because this is the maximum period of sickness
absence if there is no complete RTW. All cases in which
the sickness absence continued after the end of the data-
collection (September 2008) were also censored. This
concerned a minority of the cases, all belonging to one
group practice.
Partial RTW and the percentage of RTW were not
included in any of the analyses because the relevant
information obtained from the employers on this subject
was not consistent.
To identify the determinants for the duration of the
sickness absence, we constructed a Cox regression model.
First, we assessed the univariate associations. We chose the
following independent variables based on literature: gen-
der, age, ethnicity, group practice, attribution of the
employee, HLSSS, depressive symptoms, health anxiety
symptoms, distress symptoms, panic disorder and anxiety
disorder. The significant univariate determinants were
included in a first Cox regression model for multivariate
associations. Finally we removed the non-significant
determinants from this model to construct a second Cox
regression model.
Results
The eligible study population consisted of 812 sick-listed
employees, of whom 489 participated in this study (response
60.2%) as described elsewhere [13]. We retrieved follow-up
data from 401 employees (follow-up rate: 83.6%). For 80
sick-listed employees no follow-up data could be retrieved
because of missing data in the local computer registration
system of one of the two participating occupational health
services. For eight sick-listed employees follow-data were
incomplete.
Participants with no follow-up were comparable to those
who completed the follow-up with regard to gender, age,
level of education and PHQ-15 score, but in the non-
response group more employees belonged to ethnic
minority groups (20% vs. 12%, P = 0.017).
The baseline characteristics of the PHQ15? and
PHQ15- group are presented in Table 1. The total number
of days and frequency of sickness absence during 1 year
before baseline sickness absence were comparable.
The median duration of sickness absence was 78 days
longer (P = 0.039) for employees with high levels of
somatic symptom severity than for employees with mod-
erate, mild and minimal levels of symptoms severity. The
median duration of sickness absence in the total study
population was 273 days.
The long-term outcomes of the sickness absence are
shown in Table 3. In the PHQ15? group more employees
were still disabled after 2 years, and more employees were
discharged because of problems in the employer-employee
relationship.
In univariate analyses the duration of sickness absence
was associated with HLSSS, depression symptom score,
anxiety disorder, health anxiety score, distress, age and
group practice 2 (See Table 4).
The Cox regression analysis (see Table 5, Model 1) with
the univariate significant determinants showed that older
age and health anxiety contributed to a longer duration of
sickness absence. Group practices 2, 4 and 5 contributed to
a shorter duration of sickness absence. After removing the
multivariate non-significant determinants other than having
HLSSS (Table 5, Model 2), having HLSSS showed also to
be also a significant determinant as health anxiety score, age
and group practices 2, 4 and 5. Posthoc analysis showed that
health anxiety was a confounder of the relationship between
268 J Occup Rehabil (2010) 20:264–273
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anxiety disorder and distress on the one hand and duration
of sickness absence on the other hand.
In group practice 1 with an over-representation of
middle sized non-profit organizations like educational,
local government and health care organisations and in
group practice 3, with many small sized organizations in a
rural area, there was also a longer duration of sickness
absence. Group practice 2 with large government organi-
sations (non-profit), with each OHP being responsible for
*2,500 employees of the same organisation, and group
practices 4 and 5 with a mix of middle sized organizations
contributed also to shorter duration of sickness absence.
Discussion
We found a longer duration of sickness absence among
sick-listed employees with HLSSS (340 days) than among
employees with lower levels of somatic symptom severity
(262 days) in this sample of long-term sick-listed
employees. These findings are in line with earlier findings
that longer lasting higher levels of somatic symptom
Table 3 Sickness absence outcomes
Percentage Total
N = 401
PHQ 15?
N = 58
PHQ 15-
N = 343
Total percentage of employees with complete return to work 83.3 70.7 85.4
In combination with discharge 1.7 1.7 1.7
Total percentage of employees staying disabled 16.7 29.3 14.6
In combination with discharge because of no further possibilities for work 2.7 5.2 2.3
In combination with discharge due to problems in the employer-employee relationship 2.5 6.9 1.7
v2 = 7.7; df 1, P = 0.005
Table 4 Univariate associations determinants of duration of com-
plete RTW
HR (95% CI) P
PHQ-15? 0.63 (0.45–0.88) 0.007
Female gender 1.02 (0.82–1.27) 0.838
Age (per year) 0.98 (0.97–0.99) \0.001
Autochthon 1.19 (0.84–1.69) 0.316
Level of education 0.059
Low 1.00
Middle 1.39 (1.03–1.89) 0.034
High 1.44 (1.05–1.99) 0.024
Group practice 0.046
1 1.00
2 1.63 (1.13–2.35) 0.008
3 1.08 (0.78–1.50) 0.637
4 1.35 (0.97–1.87) 0.076
5 1.39 (0.96–2.02) 0.080
PHQ9 0.97 (0.96–0.99) 0.002
Whitely index 0.94 (0.90–0.97) 0.001
Distress (per 8 on 4-DSQ) 0.90 (0.82–0.98) 0.014
PHQ panic disorder 0.69 (0.42–1.14) 0.145
PHQ other anxiety disorder 0.65 (0.47–0.91) 0.011
Employees attribution 0.822
Physical 1.00
Mental 1.14 (0.82–1.57) 0.438
Physical and mental 1.11 (0.84–1.47) 0.464
Physiologic 1.11 (0.60–2.04) 0.745
Table 5 Cox regression determinants of duration of complete RTW
HR (95% CI) P
Model 1
PHQ? 0.69 (0.46–1.03) 0.073
Age (per year) 0.97 (0.96–0.98) \0.001
PHQ-9 0.99 (0.95–1.03) 0.487
Whitely 0.95 0.91–1.00) 0.037
Distress (per 8 on 4DSQ) 1.01 (0.86–1.19) 0.915
PHQ other anxiety disorder 0.92 (1.25–3.13) 0.679
Group practice 0.002
1 1.00
2 2.11 (1.34–3.32) 0.001
3 1.30 (0.86–1.99) 0.217
4 1.85 (1.21–2.83) 0.005
5 1.98 (1.25–3.13) 0.004
Model 2
PHQ? 0.65 (0.46–0.93) 0.017
Age (per year) 0.98 (0.97–0.99) \0.001
Whitely 0.94 (0.91–0.98) 0.003
Group practice 0.011
1 1.00
2 1.64 (1.14–2.36) 0.008
3 1.03 (0.74–1.43) 0.869
4 1.43 (1.03–2.00) 0.033
5 1.50 (1.03–2.18) 0.032
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severity result in more disabilities [3], a longer sickness
absence [10, 11] and more lasting disabilities [10].
In contradiction to the findings mentioned above, the
total amount of sickness absence (days and frequency)
before baseline sickness absence was not higher among
employees with HLSSS. It is unclear whether or not this
would have been the same in a longer-term retrospective
study. The role of selection by lasting disabilities and
discharge of sick-listed employees with HLSSS must also
be taken into account. Another factor could be that
employees with HLSSS manage to continue working in
spite of their symptoms for a certain period of time, during
which fear for health-related job loss (HRJL) could be an
important factor, after which they have a longer period of
sickness absence.
We found an indication that HLSSS more often con-
tributed to discharge during sickness absence, because of
problems in the employer-employee relationship. From a
longitudinal observational study it is not possible to draw
conclusions about causal relationships, but our results show
that sick-listed employees with HLSSS, and an associated
decrease in health related functioning, are at risk for HRJL
and a longer period of sickness absence. This suggests that
HLSSS contribute to the transition from a working
employee to an unemployed and disabled patient.
The Cox regression analysis showed that HLSSS and
health anxiety, but not psychiatric co-morbidity (depres-
sive, anxiety and panic disorder) contribute to a longer
duration of sickness absence. This is in line with the studies
of Barsky et al. [4] and Harris et al. [5], who found in a
primary care population that HLSSS showed stronger
associations with functional limitations and medical con-
sumption than with psychiatric co-morbidity. Another
explanation might be that psychiatric co-morbidity is
managed well by OHPs and treating physicians according
the guidelines for common mental disorders (CMDs).
Health anxiety showed to be a determinant. So for OHPs
it is besides the recognition of HLSSS important to rec-
ognize the health anxiety in order to give adequate reas-
surance. In employees with temporary and moderate levels
of health anxiety this may be enough to continue the pro-
cess of RTW. In employees with persistent and high levels
of health anxiety which result in hampering process of
RTW a referral for cognitive behavioral therapy (CBT) is
according literature the best intervention [26, 27].
Determinants that are not directly symptom related that
hamper RTW are age and certain factors of organization
and occupational health care. We know from older
employees that they have a graduate decline in physical
abilities and that with increasing age the amount of somatic
co-morbidity grows. It can be imagined that this attributes
to fatigue, as the Maastricht Cohort Study [28, 29] shows
and to sickness absence [30]. A study of Roelen et al. [31]
showed that worse working conditions and age are asso-
ciated with more self-reported symptoms. Furthermore,
although older employees report less mental disorders,
higher age is related to less recovery of depression [32]. A
review [8] reported only an inconsistent weak association
between older age and worse prognosis, but according to
our data the combination of older age and specific work
conditions is a risk factor when an employee gets sick-
listed, so it is important to give these employees extra
guidance.
The influence of group practices on duration of sickness
absence might indicate that employees in middle sized non-
profit organisations and also their employers, have major
difficulties in mastering the process of RTW. From the
results of earlier studies [33, 34] we know that certain non-
profit branches such as education and local government
have a longer duration of sickness absence, and more
fatigue and chronic ill employees, than employees in profit-
orientated branches. As group practice 2 with large gov-
ernmental organizations attributed to a shorter duration of
sickness absence there must be other factors as these
organizations are also non-profit organizations. Possible is
that larger non-profit organizations, especially when central
government, have higher quality of internal processes.
Their occupational health service is more centralized and
can therefore be more specialised. Specific conclusions are
not possible from our data.
Strengths and Limitations
A strength of our study is that, to our knowledge, this is the
first large-scale study of sickness absence in sick-listed
employees with a follow-up of 2 years, after baseline
measurements with validated questionnaires, assessing
somatic symptom severity, psychiatric morbidity, OHP
diagnosis and the attribution of the employee. The duration
of sickness absence was measured with computer-regis-
tered data, which are more accurate than measurements
based on self-report.
The participation of five different group practices loca-
ted in urban and rural areas, and the participation of
employees from different branches of small and large
companies, enhances the generalisability of the results.
From the results of our longitudinal observational study,
no conclusions can be drawn with regard to the underlying
causes of somatic symptom severity. This is especially
important with regard to the associations between somatic
symptom severity on the one hand, and psychiatric co-
morbidity, distress and health anxiety on the other hand.
An important limitation is that self-report questionnaires
were used for our main outcomes, and no medical exami-
nation was performed to find somatic explanations for the
multiple physical symptoms. Such an examination is
270 J Occup Rehabil (2010) 20:264–273
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necessary to confirm that a physical symptom can not be
explained by a somatic disease. However, it should be
noted that the OHPs in their consultations usually ask and
check for somatic causes, and perform physical examina-
tions on indication. The median duration of sickness
absence of 6 months at inclusion, is that long that many
somatic causes will have manifested themselves. Further-
more, the questionnaires we used were well validated, and
in the literature there is enough evidence that the PHQ is
moderate reliable, but better than other comparable ques-
tionnaires, in indicating medically unexplained somatic
symptoms [3, 17, 18].
Our sample consisted of sick-listed employees, who
were included after a mean sickness absence of 6 months.
In the total study population there was a median sickness
absence of 273 days, illustrating that our findings relate to
a population of employees with long-term sickness
absence. On the one hand, we can draw no conclusion
about short-term sickness absence in relation to somatic
symptom severity, but on the other hand our findings
indicate that HLSSS are associated with lasting disabilities,
resulting in more disability pensions.
The small number of employees with HLSSS in our
study resulted in broad confidence intervals in the results of
the Cox regression analysis.
Implications for Practice
Since high HLSSS appears to be a predictor for long-term
sickness absence [10] and HRJL [15], OHPs’ recognition
of these symptoms should be improved.
The results of our earlier study [12] showed that OHPs
tend to label HLSSS as signs of mental disorders, without
diagnosing somatization as such. Even accepting this, due
to difficulties in the categorisation of HLSSS [35, 36], the
sick-listed employees should be screened by the OHP for
HLSSS and this can be done reliably with the PHQ-15.
Adhering to the guidelines for the management and
treatment of employees with medically unexplained
somatic symptoms is important. There do exist guidelines
for the treatment of patients with functional syndromes,
[37] which also can be seen as clusters of medically
unexplained somatic symptoms, and a multidisciplinary
guideline for ‘somatic insufficient explained physical
symptoms’ is being authorized in the Netherlands [38].
Morbidity and co-morbidity, and the adequacy of
treatment, should be explored, as well as contributing
factors at work and at home and coping styles. The
employee should be asked to formulate a prognosis for
RTW, because this is an important prognostic factor [14,
39].
When the process of RTW is hampered, early inter-
vention should be considered. Reviews [40, 41] show that
patients with functional syndromes and somatoform dis-
orders with hampered recovery can benefit from cognitive
behavioral therapy and multidisciplinary treatment. An
interesting possibility is collaborative care [42], in which
the employee has a consultation with the psychiatrist and
the OHP together. This has been found to be effective in
general practice [39].
Especially after recognising HLSSS in older employees,
the OHP should check whether these employees have
problems with the balance between their abilities and their
workload.
Since it is known that education and local government
branches have a longer duration of sickness absence, and
more fatigue and chronic ill employees, than employees in
profit-orientated branches [33, 34]. In these branches
employers and OHPs should pay extra attention to
employees with HLSSS in order to prevent and limit
sickness absence.
Implications for Research
Kant et al. [43] indicated that in certain cases early con-
sultation with the OHP before actual sickness absence is
effective in reducing sickness absence in office workers
who are at high risk for long-term sickness absence. We
recommend an intervention study to assess the effective-
ness of early consultation and management according to
guidelines for employees with medically unexplained
somatic symptoms.
There is also a need for more information on the course
of medically unexplained somatic symptoms in sick-listed
employees. A follow-up study based on validated ques-
tionnaires at different measurement moments (e.g. 6, 12,
24 months), will be useful, to establish the prognostic
determinants more precisely.
Our findings about the influence of group practice are
exploratory and further research is needed about which
factors in organizations and occupational health care
determine duration of sickness absence in sick-listed
employees with medically unexplained somatic symptoms.
Final Conclusions
In conclusion, we found that HLSSS contribute to longer
sickness absence, long-term disability and discharge. This
indicates that HLSSS contribute to the ‘transition’ of
working employees to a disabled and/or unemployed sta-
tus. Especially at risk are employees with HLSSS accom-
panied with health anxiety, older employees and employees
in certain organizations possibly in combination with lower
level of occupational health care. We recommend that
OHPs use the PHQ-15 to assess somatic symptom severity
and to investigate and eliminate barriers for RTW.
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